Medtronic creates history with FDA approval of its novel PulseSelect Pulsed Field Ablation System to treat atrial fibrillation Medical Device Investing
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer Market News
Consumer Trends Shaping Functional Beverage Market and Presenting Investment Opportunities Biotech Investing
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® in adults with paroxysmal nocturnal hemoglobinuria Life Science Investing
